Neuroblastoma
Conditions
Keywords
Neuroblastoma
Brief summary
Historically, participation in clinical research is highly skewed towards particular demographic groups of people. This study will invite several participants to gather a wide range of information on clinical trial experiences for neuroblastoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of neuroblastoma. The data collected from this study will help improve future outcomes for all neuroblastoma patients as well as those in under-represented demographic groups.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Confirmed diagnosis of neuroblastoma * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Exclusion criteria
* Women of childbearing potential without a negative pregnancy test; or women who are lactating. * Any serious and/or unstable pre-existing medical disorders * Enrolled in another research study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to enroll in a neuroblastoma clinical trial | 3 months |
| Rate of patients who remain in neuroblastoma clinical trial to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed